US Corporate Board Director Changes SEC Filings — March 25, 2026

25-03-2026

Brand Engagement Network Inc. announced that Bernard Puckett notified the Board he will step down as Chairman and resign as a director effective March 31, 2026, after serving as Interim Chairman since August 2025 and Board member since April 2023; his departure is not due to any disagreements. The Board appointed independent director Jon Leibowitz as the new Chairman effective April 1, 2026. Mr. Leibowitz brings extensive experience from roles at the Federal Trade Commission, Davis Polk & Wardwell LLP, and as Chairman of the National Consumers League.

• ·Puckett served as Chair of the Audit Committee and member of Compensation Committee and Nominating and Corporate Governance Committee.
• ·Leibowitz currently serves as Chair of the Nominating and Corporate Governance Committee and member of the Audit Committee.
• ·Resignation letter from Puckett dated March 20, 2026, attached as Exhibit 17.1.

25-03-2026

On March 18, 2026, Ingredion Incorporated's Board of Directors elected Jason Payant as Interim Chief Financial Officer effective April 1, 2026, succeeding James D. Gray, whose resignation as EVP and CFO was effective March 31, 2026. Mr. Payant, age 55, has served the company since 2012 in various senior finance roles, including Vice President, Finance, Global Texture & Healthful Solutions since November 2025. He will receive $25,000 monthly cash compensation in addition to his existing compensation and benefits during his interim tenure.

• ·Jason Payant previously served as Vice President, Finance, Food & Industrial Ingredients U.S./Canada from January 2024 to November 2025, Interim Vice President, Investor Relations from September 2021 to October 2022, and Vice President, Finance from October 2017 to January 2024.
• ·No arrangements or understandings with other persons for Mr. Payant's selection; no material transactions involving Mr. Payant or his family.
• ·James D. Gray's resignation reported on January 27, 2026.

25-03-2026

HBT Financial, Inc. announced the appointment of Michael J. Morton to the Board of Directors of HBT Financial and Heartland Bank, effective April 1, 2026, with his initial term expiring at the 2026 Annual Meeting of Stockholders. Mr. Morton brings nearly 40 years of banking experience, including as Vice Chair of U.S. Commercial Banking at BMO (2020-2023) and Executive Vice President and Chief Credit Officer at MB Financial (2014-2019). As of December 31, 2025, HBT Financial reported total assets of $5.1B, total loans of $3.5B, and total deposits of $4.4B.

• ·HBT Financial operates 83 full-service branches in Illinois, eastern Iowa, and suburban St. Louis.
• ·Mr. Morton holds a BS from Illinois State University and an MBA from DePaul University.
• ·Contact: HBTIR@hbtbank.com, (309) 664-4556

25-03-2026

Maze Therapeutics announced positive topline Phase 2 HORIZON data for MZE829 in broad AMKD, with a 35.6% mean uACR reduction at week 12 (61.8% in severe FSGS patients), supporting advancement to a pivotal program, alongside plans for two Phase 2 trials of MZE782 in PKU and CKD in 2026. Cash position strengthened to $360.0M as of Dec 31, 2025 (up from $196.8M in 2024), providing runway into 2028, and Neil Kumar, Ph.D. was appointed to the Board. However, FY2025 net loss widened to $131.1M from a $52.2M profit in 2024, driven by no license revenue (vs. $167.5M in 2024) and increases in R&D expenses (30%) and G&A expenses (31%).

• ·No serious adverse events or severe treatment-related AEs observed in HORIZON trial.
• ·MZE782 Phase 2 POC trials to initiate mid-2026 (PKU) and H2 2026 (CKD).
• ·Conference call held March 25, 2026 at 8:00 am EDT.
• ·Tiered royalties from Shionogi: low double-digits to 20% on net sales.

25-03-2026

Apimeds Pharmaceuticals US, Inc. (APUS) filed an 8-K on March 25, 2026, disclosing the Second Amendment to its Bylaws dated March 20, 2026, under Items 5.02 (Director/Officer Departure/Election), 5.03 (Bylaws Amendment), 8.01, and 9.01. The amendments restate Section 17 to require Board vacancies to be filled solely by the affirmative vote of a majority of shares of capital stock entitled to vote at a stockholders' meeting or by written consent. Section 47 is restated to empower both the Board (by majority of authorized directors) and stockholders (by majority vote) to adopt, amend, or repeal the Bylaws.

• ·Filing Items: 5.02 (Director/Officer Departure/Election), 5.03 (Amendments to Bylaws), 8.01 (Other Events), 9.01 (Exhibits)

25-03-2026

Generac Holdings Inc. disclosed preliminary full-year 2025 financial results via Exhibit 99.1 in an 8-K filing, reporting net sales of $4.2B and Adjusted EBITDA of $716M for the twelve months ended December 31, 2025. The Residential segment led with $2.5B in net sales and $558M in Adjusted EBITDA, while the Commercial & Industrial segment contributed $1.8B in sales but a lower $200M in Adjusted EBITDA. Income before provision for income taxes totaled $199M after significant adjustments including $158M in legal/regulatory provisions and $71M in interest expense.

• ·Interest expense: $71M
• ·Depreciation and amortization: $195M
• ·Provision for legal, regulatory, and other costs: $158M
• ·Non-cash share-based compensation expense: $50M
• ·Change in fair value of investments: $21M

25-03-2026

Hagop Kozanian, Senior Vice President of Texas Instruments Incorporated (TXN), announced his intention to retire effective August 31, 2026, as disclosed in an 8-K filing on March 25, 2026. The filing was signed by Katharine Kane, Senior Vice President, Secretary and General Counsel. No information on a successor or any financial impact was provided.

• ·Company headquarters: 12500 TI Boulevard, Dallas, Texas 75243
• ·Registrant’s telephone number: (214) 479-3773
• ·Common Stock, par value $1.00, trading symbol TXN on The Nasdaq Global Select Market

25-03-2026

Conduent Incorporated terminated the employment without cause of Mark Prout, Executive Vice President and Chief Information and Technology Officer, effective March 24, 2026. Mr. Prout is entitled to compensation and benefits under the Company's U.S. Executive Severance Policy. No successor was named and no financial details on severance were disclosed.

25-03-2026

On March 20, 2026, Rodger R. Schwecke, Chief Operating Officer of Southern California Gas Company (a subsidiary of Sempra), provided notice of his retirement effective August 1, 2026, after more than 44 years of service with the Sempra family of companies. The Form 8-K was filed on March 25, 2026, and signed by Maryam S. Brown, Chief Executive Officer and President. No financial impacts or successor details were disclosed.

• ·No successor named for the COO position.
• ·Registrant details: California incorporation, Commission File Number 1-0140, IRS EIN 95-1240705.

25-03-2026

On March 23, 2026, Jae A. Evans resigned from the Board of Directors of Isabella Bank Corporation and its subsidiary Isabella Bank, effective as of the close of business on that date. There is no disagreement, known to an executive officer of the Corporation, between the Corporation and Mr. Evans on any matter relating to the Corporation’s operations, policies, or practices. The 8-K filing was submitted on March 25, 2026.

25-03-2026

Calumet, Inc. (NASDAQ: CLMT) announced that Board member Jennifer Straumins will not seek re-election and retire at the end of her current term, expiring at the 2026 Annual Meeting of Stockholders. Straumins joined the Board in July 2024, previously served on Calumet GP, LLC's board from February 2021 to July 2024, and was an employee for 13 years, contributing to Strategy and Growth and Risk Committees. Leadership expressed gratitude for her contributions, with the Board to evaluate composition for strategic alignment.

• ·Headquartered in Indianapolis, Indiana; operates twelve facilities throughout North America.
• ·Investor contact: John Kompa (317-957-5237, John.Kompa@calumetspecialty.com).
• ·Public Relations contact: Media Oakes (317-957-5319, Media.Oakes@calumetspecialty.com).

25-03-2026

On March 19, 2026, the Boards of Directors of Orange County Bancorp, Inc. and its wholly owned subsidiary Orange Bank & Trust Company amended the employment agreement of President and CEO Michael J. Gilfeather, extending it through March 31, 2029, with no other changes. They also amended his Performance-Based Supplemental Executive Retirement Plan Participation Agreement to provide a discretionary $125,000 employer contribution for the 2028 Plan Year, which will cliff vest on March 30, 2029. The amendments will be filed as exhibits in the Company's Form 10-Q for the quarter ending March 31, 2026.

• ·Amendments executed on March 19, 2026; filing dated March 25, 2026

25-03-2026

ONEOK, Inc. (NYSE: OKE) announced that directors Gerald B. Smith and Pattye L. Moore will retire from the board at the end of their current terms on May 20, 2026, coinciding with the 2026 Annual Meeting of Shareholders. Smith, who joined in 2020, is retiring per the company's mandatory director retirement age policy, while Moore, a board member since 2002, has elected to retire. Company leadership expressed gratitude for their contributions during ONEOK's significant transformation into a leading midstream operator.

• ·ONEOK is headquartered in Tulsa, Oklahoma and is an S&P 500 company.
• ·Investor Relations contact: Megan Patterson (918-561-5325, ONEOKInvestorRelations@oneok.com).
• ·Media Relations contact: Charlsey Phillips (918-510-1664, Media@oneok.com).

25-03-2026

Civeo Corporation announced that director Charles Szalkowski notified the Board of his retirement effective at the 2026 annual general meeting, with no disagreement on operations, policies, or practices. He will continue serving until the meeting. As previously disclosed, the Board size will be reduced to nine directors effective at the 2026 Annual Meeting.

• ·Announcement previously disclosed Board size reduction on November 28, 2025

25-03-2026

On March 23, 2026, Better Home & Finance Holding Company elected Hugh R. Frater as a director and member of the Board’s audit committee, effective immediately, with the Board confirming his independence under Nasdaq rules. Mr. Frater’s term expires at the 2026 annual stockholder meeting or until his successor is qualified. He will receive compensation per the Company’s Director Compensation Policy, including annual cash and equity retainers of $150,000 each, plus $7,500 each for audit committee service, prorated from commencement.

• ·Cash retainers paid quarterly in arrears; equity retainers vest on business day preceding annual stockholder meeting.
• ·Compensation prorated to reflect Mr. Frater’s service commencement date.
• ·Mr. Frater to enter standard indemnification agreement; no arrangements/understandings for selection, no family relationships, no material interests under Item 404(a) of Regulation S-K.

25-03-2026

SentinelOne, Inc. appointed Barry Padgett, age 55 and current Chief Growth Officer, as President and Chief Operating Officer effective March 24, 2026, following his role as interim Chief Financial Officer from January to March 2026. Compensation includes an annual base salary of $600,000, target annual cash bonus of 100% of base salary, and $10.0 million in RSU and PSU awards vesting starting August 5, 2026, with PSUs tied to performance metrics through fiscal 2030. No family relationships or reportable transactions under Item 404(a).

• ·Barry Padgett previously served as CEO of Amperity (March 2022-June 2024), President and COO at Amperity (April 2020-February 2022), Chief Revenue Officer at Stripe (March 2019-April 2020), and President of SAP SE (November 2016-February 2019).
• ·RSUs vest 1/16th on August 5, 2026 and each subsequent monthly Vesting Date (5th of month).
• ·PSUs vest based on performance metrics for FY ending Jan 31, 2027-2030, certified by Compensation Committee no later than April 30 following each year.
• ·Equity grant calculated using trailing 30-day average closing price up to April 15, 2026.

25-03-2026

On March 19, 2026, Lindblad Expeditions Holdings, Inc. appointed Rear Admiral Keith Taylor (Ret.), its Chief Maritime Officer, as an executive officer. Mr. Taylor, who joined the company in April 2025, brings over 30 years of U.S. Coast Guard experience and prior leadership as EVP of Fleet Operations for Carnival Corporation subsidiaries, managing 41 cruise ships. His compensation package includes an initial base salary of $330,000, with target annual cash bonus and equity awards each equal to 75% of base salary.

• ·Mr. Taylor, age 64, was Principal of Keith A. Taylor & Associates LLC from January 2023 to March 2025.
• ·Prior roles include Commander of the 13th Coast Guard District and various command, operational, and engineering assignments in U.S. Coast Guard.
• ·Education: Master of Business Administration (Sloan Fellow) from Massachusetts Institute of Technology, Master of Science in Industrial Administration from Purdue University, U.S. Coast Guard Academy graduate with honors.
• ·No arrangements or understandings with other persons for appointment; no family relationships with directors/officers; no material interests under Item 404(a) of Regulation S-K.

25-03-2026

On March 19, 2026, Alena Brenner resigned as Executive Vice President, General Counsel, and Corporate Secretary of Cornerstone Building Brands, Inc. to pursue another professional opportunity, with no disagreement with the company, and will remain in her role until April 17, 2026; the company plans to initiate a search for a replacement. Separately, on March 24, 2026, CEO Gunner Smith entered into an agreement for two retention bonus awards, each $1,000,000, contingent on continued employment through December 31, 2026, and December 31, 2027, respectively.

• ·Award agreement details to be filed in Quarterly Report on Form 10-Q for period ending April 4, 2026
• ·Resignation notice date: March 19, 2026; 8-K filing date: March 25, 2026

25-03-2026

On March 19, 2026, Dr. Sheldon Paul resigned from the Board of Directors and the Cybersecurity and Technology Committee of CID HoldCo, Inc., effective immediately, ahead of his term expiring at the annual stockholders' meeting on April 30, 2026. The Board's Nominating and Corporate Governance Committee plans to search for a new independent director to fill the vacancy following the annual meeting. No successor has been appointed yet, and the resignation was notified during normal governance processes.

• ·Dr. Paul was one of two directors whose terms were scheduled to expire at the April 30, 2026 annual meeting.
• ·Company confirmed as emerging growth company.
• ·Principal executive offices at 5661 S Cameron St, Suite 100, Las Vegas, NV 89118.

25-03-2026

Jefferies Credit Partners BDC Inc. sold 734,811.134 unregistered Class I common shares and 6,095.445 Class S common shares at a NAV of $14.43701 per share (as of February 28, 2026), raising $10,608,475.60 and $88,000.00 respectively from third-party investors, exempt under Section 4(a)(2), Regulation D, and/or Regulation S. On March 19, 2026, the board appointed Ryan Schindele as permanent Chief Financial Officer, following his role as Interim CFO since September 30, 2025.

• ·Share sales based on NAV as of February 28, 2026, with final number of shares determined on March 20, 2026
• ·Ryan Schindele served as Interim CFO since September 30, 2025; no family relationships, arrangements, or reportable transactions under Item 404(a) of Regulation S-K

25-03-2026

Recursion Pharmaceuticals (Nasdaq: RXRX) announced Vicki Goodman, M.D., as incoming Chief Medical Officer effective April 6, 2026, succeeding David Mauro, M.D., Ph.D., who is transitioning out after approximately three years. Dr. Goodman brings over two decades of oncology drug development experience from roles at Mural Oncology, Exelixis, Merck, Bristol Myers Squibb, and GlaxoSmithKline, including oversight of KEYTRUDA, OPDIVO, YERVOY, and dabrafenib. The leadership transition is framed as strengthening Recursion's clinical pipeline advancement toward key milestones, with praise for Dr. Mauro's contributions including REC-4881 progression.

• ·Announcement date: March 25, 2026
• ·Dr. Goodman's education: M.D. from Albert Einstein College of Medicine; training at University of Michigan
• ·Dr. Goodman's early career: FDA Medical Officer
• ·Recursion locations: Salt Lake City, Utah; Milton Park, Oxfordshire; New York; Montréal; London

25-03-2026

Nuvve Holding Corp. entered into an amended and restated employment agreement with CFO David Robson effective March 22, 2026, featuring a $450,000 annual base salary, revenue-based performance bonuses, up to $20,000 automobile down payment, $1,500 monthly lease payments, equity awards, and 12 months severance upon qualifying termination. Separately, on March 19, 2026, the company's warrants (exercisable for one-half share at $11.50 per full share, issued in 2021 business combination) expired by their terms and were delisted from Nasdaq, with common stock NVVE continuing to trade.

• ·Employment agreement term: March 22, 2026 to March 22, 2027.
• ·Warrants issued in connection with initial business combination consummated on March 19, 2021.
• ·Agreement approved by Compensation Committee of the Board of Directors.

25-03-2026

Effective March 23, 2026, Mark Guerin departed as Chief Financial Officer of Annovis Bio, Inc., with the departure not arising from any disagreement with the Company on operations, policies, or practices. The board anticipates appointing Maria Maccecchini, the current Chief Executive Officer, as Acting Chief Financial Officer until a permanent replacement is identified.

• ·Filing date: March 25, 2026
• ·Event date (earliest reported): March 23, 2026

25-03-2026

Exodus Movement, Inc. approved the 2026 Stock Incentive Plan in February 2026 via Board, Compensation Committee, and stockholder written consent, effective March 19, 2026. The plan authorizes 4,280,000 shares of Class A common stock for grants of stock options, restricted stock units, and other equity awards to employees, directors, and officers. It includes an automatic annual increase of 5% of outstanding common stock starting January 1, 2027, through 2036, subject to committee adjustment.

• ·Plan effective date: March 19, 2026
• ·Schedule 14C filed February 23, 2026; stockholders of record as of February 18, 2026
• ·Automatic share increase from January 1, 2027 to January 1, 2036

25-03-2026

On March 19, 2026, the Compensation Committee of Star Equity Holdings, Inc. approved modifications to the 2025 Incentive Compensation Program, awarding bonuses to executives including $268,380 RSU to CEO Jeffrey E. Eberwein, $90,000 cash and $45,000 RSU to COO Richard K. Coleman, Jr., $45,743 cash and $53,021 RSU to CAO Matthew K. Diamond, and $150,000 cash to Jacob Zabkowicz of HTS. The Committee also adopted the 2026 Executive Incentive Compensation Plan with target opportunities such as $650,000 RSU for Eberwein and the 2026 LTIP for long-term incentives through 2028. No declines or flat metrics reported in compensation adjustments.

• ·Payouts under 2026 plans based on adjusted EBITDA targets, corporate cost targets, investment division EBITDA, qualitative objectives, and for Zabkowicz, HTS adjusted EBITDA and gross profit.
• ·2026 LTIP runs from January 1, 2026, to December 31, 2028, focused on increases in adjusted common shareholders’ equity book value.

25-03-2026

On March 19, 2026, IonQ, Inc.'s Board of Directors added a seat and elected William F. Scannell, age 63, as a Class II director effective March 20, 2026, with his term expiring at the 2026 Annual Meeting of Stockholders. Mr. Scannell will serve on the Compensation Committee and receive compensation under the Company's Non-Employee Director Compensation Policy. There are no arrangements or understandings related to his selection or any material interests requiring disclosure.

• ·Election recommended by the Nominating and Corporate Governance Committee.
• ·Policy attached as Exhibit 10.26 to Form 10-K for year ended December 31, 2025, filed February 25, 2026.
• ·No direct or indirect material interest in any transaction or proposed transaction pursuant to Item 404(a) of Regulation S-K.

25-03-2026

Six Flags Entertainment Corporation (NYSE: FUN) appointed Richard Haddrill as Executive Chairman of the Board effective March 25, 2026, with Marilyn Spiegel serving as Lead Independent Director; this continues board refreshment, adding seven new directors since last summer and temporarily expanding the board to 11 members ahead of Jennifer Mason not standing for re-election at the 2026 Annual Meeting. The appointment follows John Reilly's CEO role in December 2025 and aims to enhance profitability and growth leveraging Haddrill's experience scaling Bally Technologies revenue from $550M to $1.2B and Manhattan Associates revenues by 150%. No current financial metrics or performance declines were disclosed.

• ·Six Flags operates parks across 16 states in the U.S., Canada, and Mexico, plus manages one amusement park in Saudi Arabia.
• ·Haddrill previously grew Bally Technologies share price by 7x and Manhattan Associates share price by 8x during his CEO tenures.
• ·Board size will revert to 10 members following Jennifer Mason's term expiration at 2026 Annual Meeting of Stockholders.

25-03-2026

On March 24, 2026, Gentherm Incorporated's Board approved the transition of Jaymi Wilson from Senior Vice President and General Manager, North America Automotive to Senior Vice President and Chief Strategy Officer, a role determined not to be an executive officer position, amid changes to the company's operating model. The filing provides extensive details on the Proposed Transaction involving Gentherm, Modine, and Modine's Performance Technologies business (SpinCo), including planned SEC filings such as a Form S-4 registration statement and proxy statements. No financial impacts or performance metrics are disclosed.

• ·Event occurred on March 24, 2026; filing dated March 25, 2026.
• ·Company address: 28875 Cabot Drive, Novi, Michigan 48377.
• ·Related past filings: Gentherm proxy statement filed March 27, 2025; Modine 10-K filed May 21, 2025, and proxy filed July 9, 2025.

25-03-2026

Middleby Corporation appointed Brittany Cerwin as Chief Financial Officer effective immediately, succeeding Bryan Mittelman who transitions to Special Advisor focused on completing the Food Processing business spin-off by end of Q2 2026. Cerwin, with 15 years at Middleby including roles as Chief Accounting Officer since 2023, has supported threefold revenue growth and fivefold earnings growth during her tenure. CEO Tim FitzGerald highlighted a seamless transition leveraging her deep expertise amid the company's transformation to a pure-play commercial foodservice equipment leader.

• ·Brittany Cerwin joined Middleby in 2011, served as Corporate Controller prior to Chief Accounting Officer in 2023.
• ·Bryan Mittelman served as CFO since 2019.
• ·Spin-off of Food Processing business previously announced, expected by end of second quarter of 2026.

25-03-2026

On March 20, 2026, the Board of QT Imaging Holdings, Inc. approved a base salary increase for CEO Dr. Raluca Dinu from $550,000 to $605,000 annually (10% increase), a $231,993 cash bonus, and RSU grants totaling 519,500 units (3,500 director + 16,000 first officer + 500,000 second officer). CFO Jay Jennings received a $40,576 cash bonus and 2,800 RSUs. These actions, recommended by the Compensation Committee, support executive retention with no reported declines in compensation metrics.

• ·CEO RSUs vest fully by February 15, 2030; CFO RSUs fully vest by May 15, 2029, subject to continued service.
• ·Prior CEO salary disclosed in 8-K filed August 29, 2025.
• ·All grants under 2024 Equity Incentive Plan with standard RSU agreements.

25-03-2026

UiPath (NYSE: PATH) announced that Raghu Malpani, previously Chief Technology Officer since May 2024, has taken an expanded role as Chief Product and Technology Officer, effective March 25, 2026, leading product and engineering teams while reporting to CEO Daniel Dines. This promotion positions Malpani to oversee the product roadmap, aligning AI, automation, and orchestration capabilities with customer transformation goals. No financial impacts or performance metrics were disclosed.

• ·Malpani's prior experience includes leadership roles at Microsoft across multiple product families and the global Decisions Platform team at Meta.
• ·Media contact: pr@uipath.com; Investor Relations contact: investor.relations@uipath.com

25-03-2026

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced the appointment of Jessica Chutter, a retired Managing Director and Chair of Biotechnology Investment Banking at Morgan Stanley, to its Board of Directors on March 25, 2026. Ms. Chutter, with over 40 years of experience, was involved in approximately $80B in capital raising and $85B in strategic transactions during her tenure. Company leadership, including Chairman Michael Schmertzler and CEO Matthew B. Klein, M.D., highlighted her expertise to support PTC's next stage of growth.

• ·Ms. Chutter earned a BA in Commerce/Economics from McGill University and an MBA from Harvard University.
• ·PTC is a global biopharmaceutical company focused on rare disorders with a diversified pipeline.

25-03-2026

Muzinich BDC, Inc. announced on March 23, 2026, a leadership transition effective April 1, 2026, with President and CEO Jeffrey Youle and CFO and Treasurer Paul Fehre stepping down from their executive roles but remaining on the Board; no disagreements were noted. The Board appointed Cheryl Rivkin as new CEO, Jens Ernberg as President, Rocco DelGuercio as CFO and Treasurer, and Susan Cohen as Secretary. All new executives are currently affiliated with Muzinich & Co., Inc.

• ·Departing executives expressed no disagreement on Company operations, policies, or practices.
• ·No arrangements or understandings between new appointees and the Company or other entities requiring disclosure under Item 404(a) of Regulation S-K.
• ·New appointees have prior experience at firms including Capital Dynamics, Credit Suisse, and Investcorp.

25-03-2026

On March 23, 2026, Muzinich Corporate Lending Income Fund, Inc. announced a leadership transition effective April 1, 2026, with CEO Jeffrey Youle and CFO/Treasurer Paul Fehre stepping down from their executive roles but continuing as Board members and in other capacities at Muzinich & Co., Inc., with no disagreements noted. The Board appointed Cheryl Rivkin as new CEO, Jens Ernberg as President, Rocco DelGuercio as new CFO/Treasurer, and Susan Cohen as Secretary. No related party transactions or arrangements were disclosed.

• ·Former CEO Jeffrey Youle will serve as Senior Adviser at Muzinich; former CFO Paul Fehre as Chief Operating Officer at Muzinich.
• ·Cheryl Rivkin, 56, joined Muzinich in 2003; Jens Ernberg, 56, joined in 2025; Rocco DelGuercio, 62, joined in November 2025; Susan Cohen, 42, joined in 2017.

25-03-2026

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) appointed David King to its Board of Directors effective March 23, 2026, with King joining the Audit Committee. King brings over four decades of experience in aerospace and defense, including leading Dynetics from $180 million to over $650 million in revenue before its $1.65 billion sale to Leidos, and overseeing a $1.4 billion Leidos Dynetics unit with more than 4,000 employees. Kratos Chairman Bill Hoglund highlighted King's expertise in unmanned systems, hypersonics, solid rocket motors, space systems, and scaling defense production.

• ·King served as Director of NASA’s Marshall Space Flight Center from 2003 to 2009.
• ·King currently serves as Chairman of Applied Aerospace & Defense (since Dec 2022), Compensation Committee Chairman of Thompson Gray, and Nominating Committee Chairman for Dynetics.
• ·King holds a bachelor’s degree in Mechanical Engineering from the University of South Carolina and a master’s degree in Business Administration from the Florida Institute of Technology.

25-03-2026

On March 25, 2026, the Board of Directors of Silexion Therapeutics Corp removed Ilan Levin from his position as a member of the Board, effective immediately. The removal was effected via a unanimous written determination adopted by all other Board members pursuant to Article 28.7 of the Company’s Amended and Restated Articles of Association. No reason for the removal was disclosed in the filing.

• ·Company incorporated in Cayman Islands with principal executive offices at 12 Abba Hillel Road, Ramat-Gan, Israel 5250606.
• ·Registrant is an emerging growth company.
• ·Securities registered under Commission File Number 001-42253.